Table 2.
Nose VAS symptoms (0–100), mean (SD) for all included patients, n = 366 at baseline, as well as change 3–6 months after surgery
| Nose VAS | N | Baseline, mean (SD) | Change after surgery, mean (SD) | Change % | p value |
|---|---|---|---|---|---|
| Nasal obstruction | 366 | 64.7 (20.2) | − 36.8 (26.9) | 57 | < 0.001 |
| Mouth breathing | 364 | 58.0 (27.6) | − 24.2 (30.5) | 42 | < 0.001 |
| Snoring | 358 | 49.9 (32.2) | − 16.8 (26.5) | 34 | < 0.001 |
| Apneas | 287 | 26.0 (29.2) | − 10.0 (27.8) | 38 | < 0.001 |
| Nasal discharge | 362 | 46.5 (28.8) | − 17.0 (30.0) | 37 | < 0.001 |
| Headache | 366 | 35.3 (28.0) | − 13.6 (25.2) | 38 | < 0.001 |
| Facial pain | 363 | 21.5 (25.7) | − 9.0 (24.4) | 42 | < 0.001 |
| Sinusitis | 357 | 29.7 (28.1) | − 14.9 (25.9) | 50 | < 0.001 |
| Cough | 363 | 30.1 (24.7) | − 9.4 (23.7) | 31 | < 0.001 |
| Sneezing | 365 | 42.2 (25.9) | − 9.8 (26.4) | 23 | < 0.001 |
| General health | 362 | 26.9 (25.8) | − 10.2 (25.0) | 38 | < 0.001 |
| Reduced sense of smell | 362 | 40.5 (30.5) | − 16.5 (28.0) | 41 | < 0.001 |